Lyka Labs Ltd - 500259 - Public Announcement To Equity Shareholders Of Lyka Labs Limited
Please find enclosed herewith the Public announcement to equity shareholders of Lyka Labs Limited24-11-2021
24-11-2021
Lyka Labs Ltd - 500259 - Open Offer
Arihant Capital Markets Ltd ("Managers to the Offer") has submitted to BSE a copy of Public Announcement to the Equity Shareholders of Lyka Labs Ltd ("Target Company").24-11-2021
LYKA LABS LTD. - 500259 - Merger Of Lyka Exports Limited With Lyka Labs Limited
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered Merger of Lyka Exports Limited, a subsidiary Company with Lyka Labs Limited, Holding Company w.e.f 01 April, 2022 subject to requisite approval of Securities and Exchange Board of India (SEBI),and other applicable requisite authorities29-10-2021
LYKA LABS LTD. - 500259 - Un-Audited Financial Results For The Quarter And Six Months Ended 30 Th September, 2021
Un-audited Standalone and Consolidated Financial Results for the quarter and six months ended 30th September, 2021.29-10-2021
LYKA LABS LTD. - 500259 - Board Meeting Outcome for Outcome Of Board Meeting Held On 29Th October, 2021
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 the Board of Directors at its Meeting held today considered and approved; 1. Un-audited Standalone and Consolidated Financial Results for the quarter and six months ended 30th September, 2021 (Enclosed). 2. Merger of Lyka Exports Limited, a subsidiary Company with Lyka Labs Limited, Holding Company w.e.f 1st April, 2022 subject to requisite approval of Securities and Exchange Board of India (SEBI), and other applicable requisite authorities. Meeting was commenced at 3.00 P.M Meeting was concluded at 5.45 P.M. This is for your information and records.29-10-2021
LYKA LABS LTD. - 500259 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Company received intimation from M/s Link Intime India Private Limited (Registrar and Share Transfer Agent) today regarding Issuance of duplicate share certificate. Kindly take the same on your record.27-10-2021
Lyka Labs Ltd - 500259 - Board Meeting Intimation for Consideration Of Financial Results For The Quarter Ended 30 September, 2021
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2021 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors of Lyka Labs Limited is scheduled to be held on Friday, 29 October, 2021 at Corporate Office to consider and adopt Standalone and Consolidated Un-Audited Financial Results for the Second Quarter and Six Months ended on September, 30,2021. As informed earlier, the trading window is closed from October 01,2021 till48 hours after declaration of Un-Audited Financial Results. Kindly take the same on your record22-10-2021
LYKA LABS LTD. - 500259 - Shareholding for the Period Ended September 30, 2021
Lyka Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here20-10-2021
LYKA LABS LTD. - 500259 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018 please find enclosed Certificate for the quarter ended 30 September, 2021 received form M/s Link Intime India Pvt Ltd, Registrar and Share Transfer Agent of the Company. This is for your information and record.13-10-2021
LYKA LABS LTD. - 500259 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Piyush G HindiaDesignation :- Company Secretary and Compliance Officer11-10-2021